Syngene Charts Global Biologics Growth with India at Its Core
How Syngene International CFO Deepak Jain is Navigating Growth and Innovation in the Biotech Frontier.
Syngene’s U.S. Expansion in Bayview Baltimore Establishes Foundation for A Customer-Centric, Globally Connected CRDMO Strategy
Base to Base biotech podcast 13: Syngene commits to US market, and Nimbus Therapeutics on computational chemistry
Paradoxical Polymers Driving the Future of Clean Energy
Formulating OSDs for Poorly Soluble Drugs
Syngene Partners With Kraton To Introduce High-performance Polymer For Green Energy
Syngene’s acquisition of its first US manufacturing facility not due to geopolitical tensions
Indian pharma pivots its operations around green chemistry & sustainable environmental practices
APAC now leads global clinical development of multi-specific antibodies, accounting for over 40% of trials